Practice-changing use of the 21-gene oncotype DX breast recurrence score test in Latin American hospitals.

被引：0
|
作者：
Leonidas Gomez, Henry
Enrique Bargallo-Rocha, Juan
Jorge Billinghurst, Roberto
Nunez de Pierro, Anibal Roberto
Andres Colo, Federico
Benitez Gil, Lisandro Luis
Allemand, Carola
Leonardo McLean, Ignacio
Lema-Medina, Mauricio
Herazo-Maya, Fernando
Jose Terrier, Francisco
Gerson Cwilich, Raquel
Leon Rivera, Mauricio
Gabriela Falcon, Silvia
Eduardo Castano, Roberto
Cordeiro Oliveira, Sergio
Jakubowski, Debbie M.
Chao, Calvin Y.
机构：
[1] Oncosalud Auna, Lima, Peru
[2] Inst Nacl Cancerol, Mexico City, DF, Mexico
[3] Sanatorio Mater Dei, Buenos Aires, DF, Argentina
[4] Hosp Dr Juan A Fernandez, Buenos Aires, DF, Argentina
[5] Inst Alexander Fleming, Buenos Aires, DF, Argentina
[6] Ctr Mastol, Rosario, Argentina
[7] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[8] Hosp Univ Austral, Buenos Aires, DF, Argentina
[9] Clin Oncol Astorga, Medellin, Colombia
[10] Breast Clin Mama, La Plata, Argentina
[11] Hosp Italiano La Plata, La Plata, Argentina
[12] Ctr Med ABC, Mexico City, DF, Mexico
[13] Clin Ricardo Palma, Lima, Peru
[14] Ctr Oncol, Aliada, Lima, Peru
[15] Hosp Aleman Buenos Aires, Buenos Aires, DF, Argentina
[16] Exact Sci Corp, Redwood City, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12539
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The 21-Gene Recurrence Score and Locoregional Recurrence in Breast Cancer Patients
    Naresh K. Jegadeesh
    Sunjin Kim
    Roshan S. Prabhu
    Gabriela M. Oprea
    David S. Yu
    Karen G. Godette
    Amelia B. Zelnak
    Donna Mister
    Jeffrey M. Switchenko
    Mylin A. Torres
    Annals of Surgical Oncology, 2015, 22 : 1088 - 1094
  • [22] 21-Gene Recurrence Score Index (ONCOTYPE DX) as a predictive biomarker for neoadjuvant chemotherapy response and outcome in patients with HR+HER2-breast cancer
    Cudos, Ariadna Gasol
    Murillo, Serafin Morales
    Der-Abrain, Noemi Tuset
    Villellas, Felip Vilardell
    Cid, Laura Arbones
    Olive, Jordi Mele
    Morales, Carles Canosa
    CANCER RESEARCH, 2024, 84 (09)
  • [23] The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment
    Ethier, Josee-Lyne
    Amir, Eitan
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (04) : 307 - 313
  • [24] The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment
    Josee-Lyne Ethier
    Eitan Amir
    Molecular Diagnosis & Therapy, 2016, 20 : 307 - 313
  • [25] Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay)
    Hou, Yanjun
    Tozbikian, Gary
    Zynger, Debra L.
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (06) : 541 - 548
  • [26] Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?
    Yap, Kelly Khai Li
    Koc, Melissa
    Lu, Janice M.
    Spicer, Darcy V.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer
    Lee, Fa-Chyi
    JAMA ONCOLOGY, 2020, 6 (04) : 585 - 586
  • [28] Use of the Oncotype DX™ 21-Gene Assay to Guide Adjuvant Decision Making in Early-Stage Breast Cancer
    Alison K. Conlin
    Andrew D. Seidman
    Molecular Diagnosis & Therapy, 2007, 11 : 355 - 360
  • [29] Use of the Oncotype DX™ 21-gene assay to guide adjuvant decision making in early-stage breast cancer
    Conlin, Alison K.
    Seidman, Andrew D.
    MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (06) : 355 - 360
  • [30] Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience
    Chiru, E. D.
    Kuhar, C. Grasic
    Oseledchyk, A.
    Schotzau, A.
    Gonzalez, M. J.
    Kurzeder, C.
    Vetter, M.
    TRANSLATIONAL ONCOLOGY, 2023, 36
12345